莫那比拉韦Molnupiravir(EIDD-2801/MK4482)
物理和化学性质
| 分子式： |
C13H19N3O7 |
| 分子量： |
329.31 |
| 溶解性： |
DMSO ≥ 60 mg/mL |
| 产量： |
大批量商业化生产 |
| 包装： |
1kg/桶、10kg/桶、15kg/桶、20kg/桶 |
| 储存： |
固体粉末： 室温保存 |
| 结构式： |
 |
分析数据
| HPLC： |
纯度 >99.5% |
| H-NMR： |
结构一致 |
| 产品描述： |
Molnupiravir ;EIDD-2801 is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. EIDD-2801 has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, EIDD-2801, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. EIDD-2801 is a prodrug of EIDD-1931.
注意：受专利保护区域, 我方不予销售。Note: Areas protected by patents are not sold by us.
|
